DaVita Clinical Research Campaign Shares Stories from Participants and Researchers
DaVita Clinical Research launched its "Inspired to Give" campaign
DaVita Clinical Research® launched its “Inspired to Give” campaign, which started November 12 and runs through February 2014, features both clinical trial participants and researchers sharing their personal experiences with clinical research. The series utilizes video, Instagram and Twitter to spread the word. The campaign asks individuals to share what inspires them to give to the medical community and humankind through participation in clinical trials.
“We find that the driving force for most who participate in clinical trials is that they have someone close to them who has a disease or illness and they want to help that person,” said DCR Chief Scientific Officer Dr. Harry Alcorn. “And in additional to being altruistic, trial participants ultimately play a key role in the future of health care by helping to develop medicine for others.”
You can read the full release here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
